Paroxysmal nocturnal hemoglobinuria screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

According to the American society of hematology, screening for paroxysmal nocturnal hemolglobinuria is recommended among patients with hemoglobinuria, cytopenia, suspected myelodysplasia, negative direct coombs test intravascular hemolytic anemia, refractory anemia, and aplastic anemia with no apparent sign of intravascular hemolysis.

Screening

According to the American society of hematology, screening for paroxysmal nocturnal hemolglobinuria is recommended among patients with:^[1]
- Hemoglobinuria
- Cytopenia
- Suspected Myelodysplasia
- Negative direct coombs test intravascular hemolytic anemia
- Refractory anemia
- Aplastic anemia with no apparent sign of intravascular hemolysis
- Unexplained thrombosis especially in unusual sites as:
  - Budd-Chiari syndrome
  - Other intra-abdominal sites (eg, mesenteric or portal veins)
  - Cerebral veins
  - Dermal veins

References

↑ Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R; et al. (2005). “Diagnosis and management of paroxysmal nocturnal hemoglobinuria”. Blood. 106 (12): 3699–709. doi:10.1182/blood-2005-04-1717. PMC 1895106. PMID 16051736.

Template:WH Template:WS

[pmid16051736-1] Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R; et al. (2005). “Diagnosis and management of paroxysmal nocturnal hemoglobinuria”. Blood. 106 (12): 3699–709. doi:10.1182/blood-2005-04-1717. PMC 1895106. PMID 16051736.

[1]